valsartan has been researched along with Uterine Cervical Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, Q; Lei, J; Liao, YD; Wang, ZH; Xu, H; Zhang, YY | 1 |
1 other study(ies) available for valsartan and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
[Expression of angiotensin II type 1 receptor in cervical squamous cell carcinoma and its clinical significance].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cervix Uteri; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Lymphatic Metastasis; Neoplasm Staging; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Valine; Valsartan; Vascular Endothelial Growth Factor A | 2007 |